-
1
-
-
21844467979
-
New insights into the regulation of HDL metabolism and reverse cholesterol transport
-
Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 2005; 96:1221-1232.
-
(2005)
Circ Res
, vol.96
, pp. 1221-1232
-
-
Lewis, G.F.1
Rader, D.J.2
-
2
-
-
0033678505
-
Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: Implications for the definition of impaired fasting glucose by the American Diabetes Association
-
von Eckardstein A, Schulte H, Assmann G. Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. J Clin Endocrinol Metab 2000; 85: 3101-3108.
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 3101-3108
-
-
von Eckardstein, A.1
Schulte, H.2
Assmann, G.3
-
3
-
-
35848935411
-
HDL serves as an S1P signaling platform mediating a multitude of cardiovascular effects
-
Argraves KM, Argraves WS. HDL serves as an S1P signaling platform mediating a multitude of cardiovascular effects. J Lipid Res 2007; 48:2325-2333.
-
(2007)
J Lipid Res
, vol.48
, pp. 2325-2333
-
-
Argraves, K.M.1
Argraves, W.S.2
-
5
-
-
6344253356
-
Antiinflammatory properties of HDL
-
Barter PJ, Nicholls S, Rye KA, et al. Antiinflammatory properties of HDL. Circ Res 2004; 95:764-772.
-
(2004)
Circ Res
, vol.95
, pp. 764-772
-
-
Barter, P.J.1
Nicholls, S.2
Rye, K.A.3
-
6
-
-
33748450343
-
Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells
-
Negre-Salvayre A, Dousset N, Ferretti G, et al. Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells. Free Radic Biol Med 2006; 41:1031-1040.
-
(2006)
Free Radic Biol Med
, vol.41
, pp. 1031-1040
-
-
Negre-Salvayre, A.1
Dousset, N.2
Ferretti, G.3
-
7
-
-
33749012804
-
High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor
-
Theilmeier G, Schmidt C, Herrmann J, et al. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 2006; 114:1403-1409.
-
(2006)
Circulation
, vol.114
, pp. 1403-1409
-
-
Theilmeier, G.1
Schmidt, C.2
Herrmann, J.3
-
8
-
-
34247339395
-
High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis
-
Noor R, Shuaib U, Wang CX, et al. High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis. Atherosclerosis 2007; 192:92-99.
-
(2007)
Atherosclerosis
, vol.192
, pp. 92-99
-
-
Noor, R.1
Shuaib, U.2
Wang, C.X.3
-
9
-
-
0037434561
-
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk
-
Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348:593-600.
-
(2003)
N Engl J Med
, vol.348
, pp. 593-600
-
-
Hill, J.M.1
Zalos, G.2
Halcox, J.P.3
-
10
-
-
35448980715
-
High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1
-
Terasaka N, Wang N, Yvan-Charvet L, Tall AR. High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1. Proc Natl Acad Sci USA 2007; 38:15093-15098.
-
(2007)
Proc Natl Acad Sci USA
, vol.38
, pp. 15093-15098
-
-
Terasaka, N.1
Wang, N.2
Yvan-Charvet, L.3
Tall, A.R.4
-
11
-
-
39449100874
-
-
Epub ahead of print
-
de Souza JA, Vindis C, Hansel B, et al. Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective antiapoptotic activity. Atherosclerosis 2007 [Epub ahead of print].
-
(2007)
Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective antiapoptotic activity. Atherosclerosis
-
-
de Souza, J.A.1
Vindis, C.2
Hansel, B.3
-
12
-
-
34247866358
-
Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic β cells
-
Abderrahmani A, Niederhauser G, Favre D, et al. Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic β cells. Diabetologia 2007; 50:1304-1314.
-
(2007)
Diabetologia
, vol.50
, pp. 1304-1314
-
-
Abderrahmani, A.1
Niederhauser, G.2
Favre, D.3
-
13
-
-
0038381515
-
Insulin-secreting β-cell dysfunction induced by human lipoproteins
-
Roehrich ME, Mooser V, Lenain V, et al. Insulin-secreting β-cell dysfunction induced by human lipoproteins. J Biol Chem 2003; 278:18368-18375.
-
(2003)
J Biol Chem
, vol.278
, pp. 18368-18375
-
-
Roehrich, M.E.1
Mooser, V.2
Lenain, V.3
-
14
-
-
34547635393
-
Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: Relevance to antiapoptotic and antioxidative activities
-
Kontush A, Therond P, Zerrad A, et al. Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities. Arterioscler Thromb Vasc Biol 2007; 27:1843-1849.
-
(2007)
Arterioscler Thromb Vasc Biol
, vol.27
, pp. 1843-1849
-
-
Kontush, A.1
Therond, P.2
Zerrad, A.3
-
15
-
-
0038218405
-
Sphingosine-1-phosphate: An enigmatic signalling lipid
-
Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003; 4:397-407.
-
(2003)
Nat Rev Mol Cell Biol
, vol.4
, pp. 397-407
-
-
Spiegel, S.1
Milstien, S.2
-
16
-
-
34848849569
-
HDL particles from type 1 diabetic patients are unable to reverse the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation
-
Persegol L, Foissac M, Lagrost L, et al. HDL particles from type 1 diabetic patients are unable to reverse the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation. Diabetologia 2007; 50:2384-2387.
-
(2007)
Diabetologia
, vol.50
, pp. 2384-2387
-
-
Persegol, L.1
Foissac, M.2
Lagrost, L.3
-
17
-
-
34548501273
-
The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction
-
Wu Z, Wagner MA, Zheng L, et al. The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction. Nat Struct Mol Biol 2007; 14:861-868.
-
(2007)
Nat Struct Mol Biol
, vol.14
, pp. 861-868
-
-
Wu, Z.1
Wagner, M.A.2
Zheng, L.3
|